Velusetrag

DRUG2 trials

Sponsors

Alfasigma S.p.A., Theravance Biopharma

Conditions

Alzheimer's DiseaseGastroparesis

Phase 1

Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects

CompletedNCT01467726

Alfasigma S.p.A.Alzheimer's Disease

Start: 2011-11-30End: 2012-01-31Updated: 2025-07-08

Phase 2

The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study

CompletedNCT02267525

Theravance BiopharmaGastroparesis

Start: 2014-12-31End: 2017-06-30Updated: 2018-04-17

Related Papers

A randomized, double‐blind, placebo‐controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis

Neurogastroenterology & Motility2023-01-0914 citations